Biopharma News

May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 09, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
May 09, 2018
By BioPharm International Editors
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 08, 2018
By BioPharm International Editors
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
By BioPharm International Editors
The data and analytics company reports on the anticipated uptake of Humira (adalimumab)‎‎ biosimilars in the EU once they are launched in 2018.
May 01, 2018
By BioPharm International Editors
As Astellas Pharma winds down its Agensys research operations, the company sells the Santa Monica, CA, facility to Gilead.
May 01, 2018
By BioPharm International Editors
The companies plan to advance programs for dementia and other neurological conditions.
Apr 30, 2018
By BioPharm International Editors
The company received a complete response letter from FDA in response to the biologics license application for a proposed trastuzumab biosimilar.
Apr 20, 2018
By BioPharm International Editors
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
Apr 19, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen partners with Bristol-Myers Squibb to advance next-generation therapies for cardiovascular diseases.
native1_300x100
lorem ipsum